| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |